Ganoderic acid B | CAS:81907-61-1 | Manufacturer ChemFaces

Ganoderic acid B

ChemFaces products have been cited in many studies from excellent and top scientific journals

Product Name	Ganoderic acid B
Price:	$288 / 20mg
CAS No.:	81907-61-1
Catalog No.:	CFN92052
Molecular Formula:	C₃₀H₄₄O₇
Molecular Weight:	516.7 g/mol
Purity:	>=98%
Type of Compound:	Triterpenoids
Physical Desc.:	Powder
Source:	The fruit body of Ganoderma lucidum
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download:	COA MSDS SDF Manual
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $134.8 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Guaijaverin

Catalog No: CFN98211
CAS No: 22255-13-6
Price: $138/20mg

Calceolarioside A

Catalog No: CFN98522
CAS No: 84744-28-5
Price: $ /

Isorhyncophylline

Catalog No: CFN92553
CAS No: 6859-01-4
Price: $158/20mg

Lonicerin

Catalog No: CFN95055
CAS No: 25694-72-8
Price: $168/10mg

Astilbin

Catalog No: CFN98371
CAS No: 29838-67-3
Price: $30/20mg

Sauchinone

Catalog No: CFN90153
CAS No: 177931-17-8
Price: $60/20mg

Gancaonin N

Catalog No: CFN95066
CAS No: 129145-52-4
Price: $463/5mg

Asimilobine

Catalog No: CFN96772
CAS No: 6871-21-2
Price: $ / mg

Apigenin-7-glucuronide

Catalog No: CFN98500
CAS No: 29741-09-1
Price: $80/20mg

Chebulagic acid

Catalog No: CFN92295
CAS No: 23094-71-5
Price: $ / mg

Description:

Ganoderic acid B is a chemical marker in quality control of G. lucidum and related products. Ganoderic acid B-containing herbs has potential influence towards therapeutic window of trifluoperazine.Ganoderic acid B has antinociceptive effect; it is moderately active inhibitors against HIV-1 protease with a 50% inhibitory concentration of 0.17-0.23 mM.

Targets:

In vitro:

Int J Med Mushrooms . 2018;20(9):859-871.

Triterpenes and Soluble Polysaccharide Changes in Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), During Fruiting Growth[Pubmed: 30317980]

Abstract We analyzed the changes in triterpenes and soluble polysaccharides in Ganoderma lucidum strain G0119 during 4 growth phases in 3 regions of the fruiting bodies using reversed-phase high-performance liquid chromatography, and we also analyzed the soluble polysaccharides using high-performance size-exclusion chroma-tography-multiple-angle laser-light scattering refractive index analysis. The strong polar triterpenes decreased while weak polar triterpenes increased during the growth cycle of G. lucidum. The highest contents of Ganoderic acid B, ganoderic acid A, and ganoderenic acid B were detected in the stipe during phase II, and ganoderic acid S, ganoderic acid T, and ganoderiol B peaked in the base during phase IV. The total content of soluble polysaccharides in samples decreased after the primordium developed into a fruiting body. Two high-molecular-weight fractions were detected in the soluble polysaccharide samples: α-l,4-glucan and β-l,3-glucan, respectively. They were primarily distributed in the pileus during phase II, and both decreased after this phase. These results led us to select a more suitable growth phase and region for harvesting to obtain extracts with higher contents of triterpenes and soluble polysaccharides.

In vivo:

Biomed Chromatogr. 2013 Sep;27(9):1177-87.

Structural identification of the metabolites of ganoderic acid B from Ganoderma lucidum in rats based on liquid chromatography coupled with electrospray ionization hybrid ion trap and time-of-flight mass spectrometry.[Pubmed: 23723086]

Ganoderic acid B (GAB), a representative triterpenoid in Ganoderma lucidum, possesses various pharmaceutical effects and has been used as a chemical marker in quality control of G. lucidum and related products.
METHODS AND RESULTS:
The metabolites of GAB in vivo after its oral administration to rats were investigated by liquid chromatography coupled with electrospray ionization hybrid ion trap and time-of-flight mass spectrometry. A total of 14 metabolites of GAB in rat plasma, bile and various organs were detected and identified by direct comparison with the authentic compounds and their characteristic mass fragmentation patterns. The results showed that oxidization and hydroxylation were the common metabolic pathways for GAB in rats. Moreover, some reduction metabolites of GAB were detected in rat kidney and stomach and glucuronidation only appeared in rat bile.
CONCLUSIONS:
This is the first report on the metabolites of GAB in vivo.

Ganoderic acid B Description

Source:	The fruit body of Ganoderma lucidum
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Kinase Assay:

Afr Health Sci. 2015 Mar;15(1):146-9.

Ganoderic acid B's influence towards the therapeutic window of trifluoperazine (TFP).[Pubmed: 25834543]

Ganoderic acid B is an important bioactive ingredient isolated from Ganoderma lucidum, and exhibits various pharmacological activities. To investigate the influence of Ganoderic acid B towards the therapeutic window of trifluoperazine (TFP).
METHODS AND RESULTS:
In vitro human liver microsomes (HLMs) incubation system was used to determine the inhibition of Ganoderic acid B towards the glucuronidation of trifluoperazine (TFP). Ganoderic acid B exerted concentration-dependent inhibition towards the glucuronidation of TFP. Furthermore, Dixon plot was used to determine the inhibition type. The intersection point was located in the second quadrant in Dixon plot, indicating the competitive inhibition of Ganoderic acid B towards TFP glucuronidation. Through fitting the data using competitive nonlinear fitting equation, the inhibition kinetic parameter was calculated to be 56.7 uM.
CONCLUSIONS:
All this data indicated the potential influence of Ganoderic acid B-containing herbs towards therapeutic window of TFP. Given that the glucuronidation reaction of TFP is the probe reaction of UGT1A4, the data obtained from the present study also indicated the potential influence of Ganoderic acid-containing herbs towards the therapeutic window of drugs mainly undergoing UGT1A4-mediated metabolism.

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Antihypertensive Compound Library Triterpenoids Compound Library STAT Inhibitor Library p38MAPK Inhibitor Library NF-kB Inhibitor Library JAK Inhibitor Library IL Receptor Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	1.9354 mL	9.6768 mL	19.3536 mL	38.7072 mL	48.384 mL
5 mM	0.3871 mL	1.9354 mL	3.8707 mL	7.7414 mL	9.6768 mL
10 mM	0.1935 mL	0.9677 mL	1.9354 mL	3.8707 mL	4.8384 mL
50 mM	0.0387 mL	0.1935 mL	0.3871 mL	0.7741 mL	0.9677 mL
100 mM	0.0194 mL	0.0968 mL	0.1935 mL	0.3871 mL	0.4838 mL

CFN95526	Hainanic acid B	1637737-46-2	514.7	C₃₀H₄₂O₇
CFN95527	New compound 18	N/A	516.7	C₃₀H₄₄O₇
CFN95545	New compound 20	N/A	514.7	C₃₀H₄₂O₇
CFN90299	Ganolucidic acid A	98665-21-5	500.67	C₃₀H₄₄O₆
CFN95513	Ganolucidic acid B	98683-75-1	502.7	C₃₀H₄₆O₆
CFN92052	Ganoderic acid B	81907-61-1	516.7	C₃₀H₄₄O₇
CFN95551	Methyl ganoderate B	81907-65-5	530.7	C₃₁H₄₆O₇
CFN92991	Ganoderenic acid B	100665-41-6	514.65	C₃₀H₄₂O₇
CFN95534	Methyl ganoderenate B	N/A	528.7	C₃₁H₄₄O₇
CFN91782	(3beta,7beta,12beta,20Z)- 3,7,12- trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid	1961358-02-0	530.66	C₃₀H₄₂O₈